In March 2016, two months before joining Dana-Farber, Sara Menendez, LAT, ATC, attended LYNKED IN, an annual one-day conference hosted by Dana-Farber’s Lynch Syndrome Center. The event gave her an opportunity to meet colleagues and learn about treatment advances, screening guidelines, and prevention efforts for Lynch syndrome, an inherited and often underdiagnosed condition that increases … Read more
In December 2023, a space opened in a clinical trial at Dana-Farber of a novel targeted drug. Rosemary Conway, 68, who had stage IV lung cancer, was eager to fill it. She had been waiting nearly six years for a trial of a medicine that would target a specific genetic mutation driving the growth of … Read more
In recent decades, rates of some cancers, such as colorectal cancer, have been rising in young adults under the age of 50. One possible explanation for this rise is a parallel rise in obesity rates and changes in diet, activity levels and lifestyle. However, says Kimmie Ng, MD, MPH, director of Dana-Farber’s Young-Onset Colorectal Cancer … Read more
Headline: / / Should Cancer Patients Get the Flu Shot During COVID-19? Medically Reviewed by Candace Hsieh, RN, CIC Influenza viruses, generally referred to as the flu, are present year-round in the United States, but are most common during the fall and winter months. The best way to protect yourself, and those around you, is … Read more
People with Lynch syndrome have an elevated risk of developing colon cancer and several other cancers. For example, someone without the inherited condition has about a 5% chance of developing colon cancer. But for someone with Lynch syndrome, it could be anywhere from 22% to 74%. What if there were a way to reduce the … Read more
The number of people seeking care at the Butaro Cancer Center of Excellence in Rwanda has been rising consistently over the last decade. Prior to that, very few people in Rwanda received cancer care, not because no one had cancer but because Rwanda had virtually no cancer care services. Over the last 12 years, the … Read more
A blood test can now detect the presence of 50 different cancers — most of which do not have any other means of screening. The test, the GRAIL Galleri multi-cancer early detection (MCED) test, reports results that include a yes or no readout regarding the presence of a potential cancer, plus the most likely location … Read more
Dana-Farber’s genitourinary cancer team is devoted to research that will advance patient care and improve patient’s lives. Recently, that research — all of it years in the making — has paid off with major achievements. This includes: “We are constantly striving to improve the treatment and diagnosis of genitourinary cancers,” says Toni Choueiri, MD, director … Read more
The group of oils known as seed oils has recently come under scrutiny in various online communities. Pointing to the processing they undergo and their fatty acid make-up, some people oppose the use of these oils—which include peanut oil, sesame seed oil, canola oil, soybean oil, and others—claiming that they are unhealthy. The truth, however, … Read more
Menin, a protein located in the nucleus of various human cell types, often functions as a tumor suppressor by inhibiting excessive cell growth and division. It facilitates a complex of proteins involved in a cellular process called histone methylation, where chemical units called methyl groups are added to histone proteins that anchor DNA, thereby activating … Read more
In 2021, a novel drug called belzutifan was approved by the U.S. Food and Drug Administration (FDA) to treat clear cell renal cell carcinoma, a form of kidney cancer. Since then, Dana-Farber clinical investigator Panos Konstantinopoulos, MD, PhD, has wanted to launch a clinical trial of the drug for clear cell ovarian cancer. That vision … Read more
The Scragg family always knew it was a possibility, but it still came as a shock. It was August 2021, and Mark Scragg, then 33, was undergoing treatment for stage 4 stomach cancer. After just three months of chemotherapy and immunotherapy, scans showed no sign of the tumor first discovered in his stomach that spring … Read more
Pathologists at Dana-Farber analyze tumor samples from tissues collected from patients as part of research studies. Their goal is to learn as much as possible about the sample so that they determine the best way to diagnose the disease precisely and guide treatment decisions. As research advances, more and more factors are influencing diagnoses and … Read more
According to a new report, misinformation about science and health can lead individuals to make ill-informed decisions that aren’t in their best interest. It also has broader effects in society by causing confusion and eroding trust in institutions, including scientific institutions. Over the past two-plus years, a panel of scientific investigators gathered by the National Academies … Read more
In the midst of a lumpectomy, chemotherapy, and radiation for breast cancer, Dianne Austin thought finding a wig to cover her balding head would be easy. She quickly learned otherwise. As a Black woman, Austin desired a wig that resembled her tightly coiled, kinky and curly hair. This was 2015, and although several hospitals near … Read more
Respiratory syncytial virus, or RSV, is a common respiratory virus. RSV symptoms are similar to the common cold – congestion, runny nose, fever, and sore throat. RSV infection is usually mild, but it can be severe for infants, older adults, and individuals with immunocompromising conditions, including cancer. In infants, it can lead to pneumonia or … Read more
In 2023, Denise “Necee” Regis was brought face to face with her old art studio building on Brookline Avenue. As she walked by, she was able to identify the window that belonged to the room where she once spent the late 70s and early 80s working on a Master of Fine Arts at the Massachusetts … Read more
RAS is an oncogene, which is a gene that when mutated causes cancer. RAS (which is a family of genes including KRAS, HRAS, and NRAS) is commonly mutated in cancer. RAS mutations, usually in the KRAS protein, occur in about one in four cases of lung cancer. These gene mutations are found only in the cancer … Read more
RAS is an oncogene, which is a gene that when mutated causes cancer. RAS (consisting of a family of genes including KRAS, HRAS, and NRAS) is commonly mutated in cancer. Approximately 92 percent of pancreatic cancers have a KRAS mutation. These gene mutations are found only in the cancer cells and cause the RAS protein, … Read more
RAS is an oncogene, which is a gene that when mutated causes cancer. RAS — an abbreviation for rat sarcoma — is the most commonly mutated oncogene in human cancer. RAS mutations are found in 20% of all cancers and account for an estimated 260,000 cases per year in the U.S. and 3.4 million cases … Read more